Cancer, Advanced Completed Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00761644Doxil, Bevacizumab and Temsirolimus TrialTreatment
NCT00610493Bevacizumab and Temsirolimus in Patients With Advanced MalignancyTreatment
NCT00530907Valproic Acid and Bevacizumab in Patients With Advanced CancerTreatment
NCT00667485Rapamycin Plus Bevacizumab in Advanced CancersTreatment
NCT00980239HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverTreatment
NCT01152203Bendamustine and Bevacizumab for Advanced CancersTreatment